Lv55
1395 积分 2021-02-07 加入
Why Breakthrough Drug Discovery Platforms Need Decades to Mature: Lessons from FBDD, DEL, Aptamers, and PROTACs
16小时前
已完结
The Discovery of the Antidepressant Vortioxetine and the Research that Uncovered Its Potential to Treat the Cognitive Dysfunction Associated with Depression
2天前
已完结
Design, Synthesis, and Evaluation of Cyclopropyl-Based PD-1/PD-L1 Interaction Inhibitors Bearing a Dipeptide Tail with Improved Drug-likeness
3天前
已完结
Design, Synthesis, and Evaluation of a Potent NLRP3 Inflammasome Inhibitor with Favorable Pharmacokinetic and Safety Profiles for Chronic Inflammatory Diseases
3天前
已完结
Discovery of DT-9081, a Potent and Orally Bioavailable Small Molecule Antagonist of the EP4 Receptor for the Treatment of Solid Cancers
3天前
已完结
Discovery of Non-prostanoid EP4 Agonists for the Treatment of Inflammatory Bowel Disease
3天前
已完结
Phase 2 Trial of Icotrokinra for Patients with Ulcerative Colitis
6天前
已完结
PARP-1 selective inhibitors: A new direction in drug discovery to improve the therapeutic index of PARP-targeted cancer therapy
15天前
已完结
G protein-coupled receptors: structure- and function-based drug discovery
16天前
已完结
Synthetic Approaches to the New Drugs Approved During 2024
17天前
已完结
皖公网安备34019202002308
